Literature DB >> 2643231

Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease.

J L Ferrara1, F J Guillen, P J van Dijken, A Marion, G F Murphy, S J Burakoff.   

Abstract

We have studied the phenotype of mononuclear cells infiltrating target organs of mice with acute graft-versus-host disease after bone marrow transplantation from H-2-identical donors. Infiltrating mononuclear cells with characteristics of large granular lymphocytes (LGL) were frequently found in close association with dead or dying epithelial cells in the skin, liver, and colon. The phenotype of these putative effector cells was Thy-1+, ASGM1+, Mac-1+, Lyt-1-, Lyt-2-, Ia-, which is characteristic of LGL. Differences in the Thy-1 allele between donor and host were used to demonstrate that these cells were of donor origin. Analysis of cytolytic function in GVHD splenocytes indicated high natural killer activity and low cytolytic T lymphocyte (CTL) activity. These findings suggest that an important effector cell in systemic acute graft-versus-host disease is a large granular lymphocyte of donor origin.

Entities:  

Mesh:

Year:  1989        PMID: 2643231     DOI: 10.1097/00007890-198901000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

Review 1.  Tumor necrosis factor and immunopathology.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Characteristics of graft-versus-host disease after Lewis-to-brown-Norway rat small bowel transplantation.

Authors:  M Tanabe; N Murase; A J Demetris; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

3.  Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.

Authors:  Nirali N Shah; Kristin Baird; Cynthia P Delbrook; Thomas A Fleisher; Mark E Kohler; Shakuntala Rampertaap; Kimberly Lemberg; Carolyn K Hurley; David E Kleiner; Melinda S Merchant; Stefania Pittaluga; Marianna Sabatino; David F Stroncek; Alan S Wayne; Hua Zhang; Terry J Fry; Crystal L Mackall
Journal:  Blood       Date:  2014-12-01       Impact factor: 22.113

4.  Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.

Authors:  Zaid Al-Kadhimi; Zartash Gul; Roberto Rodriguez; Wei Chen; Daryn Smith; Alice Mitchell; Muneer Abidi; Lois Ayash; Abhinav Deol; Lawrence Lum; Stephen Forman; Voravit Ratanatharathorn; Joseph Uberti
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-16       Impact factor: 5.742

5.  Fetal natural killer cell function is suppressed.

Authors:  E Dominguez; J A Madrigal; Z Layrisse; S B Cohen
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

6.  Immunoelectron microscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation.

Authors:  M Takata; T Imai; T Hirone
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

Review 7.  Target cells in graft-versus-host disease: implications for cancer therapy.

Authors:  George F Murphy
Journal:  Clin Rev Allergy Immunol       Date:  2007-08-14       Impact factor: 8.667

8.  Evaluation of in vitro cytotoxic T lymphocyte assays as a predictive test for the occurrence of graft vs host disease.

Authors:  P Fontaine; J Langlais; C Perreault
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

9.  Kinetics of gene expression in murine cutaneous graft-versus-host disease.

Authors:  Philip B Sugerman; Sara B Faber; Lucy M Willis; Aleksandra Petrovic; George F Murphy; Jacques Pappo; David Silberstein; Marcel R M van den Brink
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.

Authors:  H Sakamoto; J Michaelson; W K Jones; A K Bhan; S Abhyankar; M Silverstein; D E Golan; S J Burakoff; J L Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.